Publication | Open Access
The <i>BRCA1</i> c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
77
Citations
14
References
2017
Year
Our results confirm that <i>BRCA1</i>*R1699Q confers an intermediate risk for BC and OC. Breast surveillance for female carriers based on mammogram annually from age 40 is advised. Bilateral salpingo-oophorectomy should be considered based on family history.
| Year | Citations | |
|---|---|---|
Page 1
Page 1